vs
Absci Corp（ABSI）与Inotiv, Inc.（NOTV）财务数据对比。点击上方公司名可切换其他公司
Inotiv, Inc.的季度营收约是Absci Corp的186.0倍（$120.9M vs $650.0K）。Inotiv, Inc.净利率更高（-23.5% vs -4548.0%，领先4524.5%）。Inotiv, Inc.同比增速更快（0.8% vs -2.3%）。Inotiv, Inc.自由现金流更多（$-10.6M vs $-29.3M）。过去两年Inotiv, Inc.的营收复合增速更高（0.8% vs -14.9%）
Absci Corp是一家结合合成生物学与人工智能技术的生物技术企业，为全球制药及生物制药合作伙伴提供集成式蛋白质工程解决方案，加速抗体、治疗性蛋白等新型生物候选药物的研发，助力满足未被覆盖的临床医疗需求。
Inotiv公司是一家注册于美国印第安纳州的合同研究组织，总部位于该州拉斐特市。公司设有两大核心业务板块：发现与安全评估业务（DSA）以及研究模型与服务业务（RMS），可为小分子候选药物、生物治疗产品及生物医疗设备提供安全评估、分析、代谢研究、CMC及法规咨询等药物开发与环境科学相关服务。
ABSI vs NOTV — 直观对比
营收规模更大
NOTV
是对方的186.0倍
$650.0K
营收增速更快
NOTV
高出3.1%
-2.3%
净利率更高
NOTV
高出4524.5%
-4548.0%
自由现金流更多
NOTV
多$18.7M
$-29.3M
两年增速更快
NOTV
近两年复合增速
-14.9%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $650.0K | $120.9M |
| 净利润 | $-29.6M | $-28.4M |
| 毛利率 | — | — |
| 营业利润率 | -4775.5% | -13.5% |
| 净利率 | -4548.0% | -23.5% |
| 营收同比 | -2.3% | 0.8% |
| 净利润同比 | -2.0% | -2.7% |
| 每股收益（稀释后） | $-0.19 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABSINOTV
| Q4 25 | $650.0K | $120.9M | ||
| Q3 25 | $378.0K | $138.1M | ||
| Q2 25 | $593.0K | $130.7M | ||
| Q1 25 | $1.2M | $124.3M | ||
| Q4 24 | $665.0K | $119.9M | ||
| Q3 24 | $1.7M | $130.4M | ||
| Q2 24 | $1.3M | $105.8M | ||
| Q1 24 | $898.0K | $119.0M |
净利润ABSINOTV
| Q4 25 | $-29.6M | $-28.4M | ||
| Q3 25 | $-28.7M | $-8.6M | ||
| Q2 25 | $-30.6M | $-17.6M | ||
| Q1 25 | $-26.3M | $-14.9M | ||
| Q4 24 | $-29.0M | $-27.6M | ||
| Q3 24 | $-27.4M | $-18.9M | ||
| Q2 24 | $-24.8M | $-26.1M | ||
| Q1 24 | $-22.0M | $-48.1M |
营业利润率ABSINOTV
| Q4 25 | -4775.5% | -13.5% | ||
| Q3 25 | -7977.2% | -4.9% | ||
| Q2 25 | -5293.9% | -4.3% | ||
| Q1 25 | -2351.9% | -2.4% | ||
| Q4 24 | -4477.3% | -12.9% | ||
| Q3 24 | -1698.7% | -10.1% | ||
| Q2 24 | -2104.0% | -19.6% | ||
| Q1 24 | -2616.7% | -36.2% |
净利率ABSINOTV
| Q4 25 | -4548.0% | -23.5% | ||
| Q3 25 | -7594.2% | -6.2% | ||
| Q2 25 | -5155.0% | -13.5% | ||
| Q1 25 | -2234.6% | -12.0% | ||
| Q4 24 | -4358.3% | -23.0% | ||
| Q3 24 | -1610.7% | -14.5% | ||
| Q2 24 | -1948.8% | -24.7% | ||
| Q1 24 | -2447.1% | -40.4% |
每股收益（稀释后）ABSINOTV
| Q4 25 | $-0.19 | $-0.83 | ||
| Q3 25 | $-0.20 | $-0.14 | ||
| Q2 25 | $-0.24 | $-0.51 | ||
| Q1 25 | $-0.21 | $-0.44 | ||
| Q4 24 | $-0.26 | $-1.02 | ||
| Q3 24 | $-0.24 | $-0.73 | ||
| Q2 24 | $-0.22 | $-1.00 | ||
| Q1 24 | $-0.22 | $-1.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $144.3M | $12.7M |
| 总债务越低越好 | — | $405.8M |
| 股东权益账面价值 | $189.4M | $109.0M |
| 总资产 | $216.3M | $734.3M |
| 负债/权益比越低杠杆越低 | — | 3.72× |
8季度趋势，按日历期对齐
现金及短期投资ABSINOTV
| Q4 25 | $144.3M | $12.7M | ||
| Q3 25 | $152.5M | $21.7M | ||
| Q2 25 | $38.0M | $6.2M | ||
| Q1 25 | $47.0M | $19.3M | ||
| Q4 24 | $112.4M | $38.0M | ||
| Q3 24 | $38.2M | $21.4M | ||
| Q2 24 | $42.9M | $14.4M | ||
| Q1 24 | $58.8M | $32.7M |
总债务ABSINOTV
| Q4 25 | — | $405.8M | ||
| Q3 25 | — | $402.1M | ||
| Q2 25 | — | $396.5M | ||
| Q1 25 | — | $399.5M | ||
| Q4 24 | $4.0M | $396.0M | ||
| Q3 24 | — | $393.3M | ||
| Q2 24 | — | $382.4M | ||
| Q1 24 | — | $380.6M |
股东权益ABSINOTV
| Q4 25 | $189.4M | $109.0M | ||
| Q3 25 | $210.3M | $136.0M | ||
| Q2 25 | $173.4M | $143.8M | ||
| Q1 25 | $198.8M | $157.7M | ||
| Q4 24 | $179.1M | $169.8M | ||
| Q3 24 | $201.3M | $170.5M | ||
| Q2 24 | $221.5M | $182.1M | ||
| Q1 24 | $240.1M | $207.2M |
总资产ABSINOTV
| Q4 25 | $216.3M | $734.3M | ||
| Q3 25 | $245.0M | $771.1M | ||
| Q2 25 | $209.9M | $759.7M | ||
| Q1 25 | $232.4M | $766.0M | ||
| Q4 24 | $213.6M | $772.9M | ||
| Q3 24 | $235.2M | $781.4M | ||
| Q2 24 | $255.5M | $774.6M | ||
| Q1 24 | $274.9M | $815.4M |
负债/权益比ABSINOTV
| Q4 25 | — | 3.72× | ||
| Q3 25 | — | 2.96× | ||
| Q2 25 | — | 2.76× | ||
| Q1 25 | — | 2.53× | ||
| Q4 24 | 0.02× | 2.33× | ||
| Q3 24 | — | 2.31× | ||
| Q2 24 | — | 2.10× | ||
| Q1 24 | — | 1.84× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-29.2M | $-5.4M |
| 自由现金流经营现金流 - 资本支出 | $-29.3M | $-10.6M |
| 自由现金流率自由现金流/营收 | -4505.4% | -8.8% |
| 资本支出强度资本支出/营收 | 15.8% | 4.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-94.2M | $-28.7M |
8季度趋势，按日历期对齐
经营现金流ABSINOTV
| Q4 25 | $-29.2M | $-5.4M | ||
| Q3 25 | $-25.0M | $14.3M | ||
| Q2 25 | $-16.9M | $-7.4M | ||
| Q1 25 | $-21.8M | $-12.8M | ||
| Q4 24 | $-17.0M | $-4.5M | ||
| Q3 24 | $-20.7M | $-2.4M | ||
| Q2 24 | $-16.8M | $-14.8M | ||
| Q1 24 | $-17.9M | $16.9M |
自由现金流ABSINOTV
| Q4 25 | $-29.3M | $-10.6M | ||
| Q3 25 | $-26.0M | $11.6M | ||
| Q2 25 | $-17.1M | $-11.5M | ||
| Q1 25 | $-21.9M | $-18.3M | ||
| Q4 24 | $-17.0M | $-9.0M | ||
| Q3 24 | $-20.8M | $-7.7M | ||
| Q2 24 | $-17.2M | $-19.2M | ||
| Q1 24 | — | $9.9M |
自由现金流率ABSINOTV
| Q4 25 | -4505.4% | -8.8% | ||
| Q3 25 | -6876.5% | 8.4% | ||
| Q2 25 | -2883.0% | -8.8% | ||
| Q1 25 | -1854.5% | -14.7% | ||
| Q4 24 | -2554.4% | -7.5% | ||
| Q3 24 | -1221.6% | -5.9% | ||
| Q2 24 | -1352.4% | -18.2% | ||
| Q1 24 | — | 8.3% |
资本支出强度ABSINOTV
| Q4 25 | 15.8% | 4.3% | ||
| Q3 25 | 254.5% | 1.9% | ||
| Q2 25 | 37.6% | 3.1% | ||
| Q1 25 | 2.1% | 4.4% | ||
| Q4 24 | 3.5% | 3.7% | ||
| Q3 24 | 2.8% | 4.1% | ||
| Q2 24 | 26.2% | 4.2% | ||
| Q1 24 | 0.0% | 5.9% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABSI
暂无分部数据
NOTV
| Research Models And Services Segment | $72.9M | 60% |
| Discovery And Safety Assessment Segment | $48.0M | 40% |
